F. Fábregues

发表

Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response.

R. Casamitjana, W. Jiménez, J. Balasch, 2000, Human reproduction.

Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study

M. Pavesi, V. Arroyo, J. Balasch, 2013, Acta obstetricia et gynecologica Scandinavica.

First-trimester repeated abortion is not associated with activated protein C resistance.

J. Balasch, D. Tàssies, J. Reverter, 1997, Human reproduction.

ALWAYS ICSI? A SWOT analysis

J. Bellver, J. García-Velasco, F. Fábregues, 2020, Journal of Assisted Reproduction and Genetics.

Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol

R. Casamitjana, W. Jiménez, V. Arroyo, 1999, Acta obstetricia et gynecologica Scandinavica.

Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment.

R. Casamitjana, J. Balasch, F. Fábregues, 1996, American journal of obstetrics and gynecology.

Risk Factors Associated with Fetal Losses in Treated Antiphospholipid Syndrome Pregnancies: A Multivariate Analysis

R. Cervera, J. Balasch, J. Font, 2001, American journal of reproductive immunology.

Infertility factors and pregnancy outcome in women above age 35.

J. Balasch, F. Fábregues, J. Vanrell, 1992, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Expression pattern of osteopontin and αvβ3 integrin during the implantation window in infertile patients with early stages of endometriosis.

J. Ordi, R. Casamitjana, J. Balasch, 2012, Human reproduction.

Osteopontin and alphavbeta3 integrin as markers of endometrial receptivity: the effect of different hormone therapies.

J. Ordi, R. Casamitjana, J. Balasch, 2010, Reproductive biomedicine online.

Osteopontin and αvβ3 integrin expression in the endometrium of infertile and fertile women

E. Campo, J. Ordi, R. Casamitjana, 2008 .

The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study.

J. Ordi, R. Casamitjana, J. Balasch, 2003, Human reproduction.

αvβ3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women

J. Ordi, R. Casamitjana, J. Balasch, 2002 .

Midluteal Endometrial Biopsy and &agr;v&bgr;3 Integrin Expression in the Evaluation of the Endometrium in Infertility: Implications for Fecundity

J. Ordi, R. Casamitjana, J. Balasch, 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation.

R. Casamitjana, J. Balasch, F. Fábregues, 2001, Human reproduction.

Integrin expression in normal and out-of-phase endometria.

J. Ordi, C. Coutifaris, R. Casamitjana, 1998, Human reproduction.

Further data favoring the hypothesis of the uterine first-pass effect of vaginally administered micronized progesterone.

R. Casamitjana, J. Balasch, D. Manau, 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Endocrinology: Midluteal immunoreactive α-inhibin serum concentrations as markers of luteal phase deficiency

R. Casamitjana, J. Balasch, F. Fábregues, 1996 .

Antiphospholipid antibodies and human reproductive failure.

J. Balasch, J. Font, D. Tàssies, 1996, Human reproduction.

Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)

J. Balasch, J. Font, J. Reverter, 1999, Human reproduction.

Is luteinizing hormone needed for optimal ovulation induction?

J. Balasch, F. Fábregues, 2002, Current opinion in obstetrics & gynecology.

A rare case of chorioamnionitis by Morganella morganii complicated by septicemia and adult respiratory distress syndrome.

F. Carmona, F. Fábregues, J. Vila, 1992, European journal of obstetrics, gynecology, and reproductive biology.

Impact of chronic endometritis in infertility: a SWOT analysis.

J. Bellver, J. García-Velasco, F. Fábregues, 2021, Reproductive biomedicine online.

Transferrin Receptor (CD71) Expression in Peritoneal Macrophages from Fertile and Infertile Women With and Without Endometriosis

R. Vilella, J. Balasch, F. Carmona, 1997, American journal of reproductive immunology.

Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.

W. Jiménez, J. Balasch, F. Carmona, 2007, Human reproduction.

Parental human leukocyte antigens and implantation failure after in-vitro fertilization.

J. Martorell., J. Balasch, F. Fábregues, 1998, Human reproduction.

Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.

J. Balasch, D. Tàssies, F. Carmona, 2004, Fertility and sterility.

Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome

W. Jiménez, V. Arroyo, J. Balasch, 1999, American Journal of Gastroenterology.

Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome.

W. Jiménez, V. Arroyo, J. Balasch, 1995, Fertility and sterility.

Neurohormonal and Hemodynamic Changes in Severe Cases of the Ovarian Hyperstimulation Syndrome

W. Jiménez, V. Arroyo, J. Balasch, 1994, Annals of Internal Medicine.

Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial.

J. Balasch, F. Carmona, D. Manau, 2008, Human reproduction.

The usefulness of endometrial biopsy for luteal phase evaluation in infertility.

J. Balasch, F. Fábregues, M. Creus, 1992, Human reproduction.

Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone

R. Casamitjana, W. Jiménez, J. Balasch, 2000, Acta obstetricia et gynecologica Scandinavica.

Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome.

J. Balasch, J. Reverter, F. Fábregues, 1996, Fertility and sterility.

Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome.

V. Arroyo, J. Balasch, F. Fábregues, 1998, Human reproduction.

Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach

W. Jiménez, V. Arroyo, J. Balasch, 1996, Acta obstetricia et gynecologica Scandinavica.

Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome.

W. Jiménez, V. Arroyo, F. Rivera, 1998, Human reproduction.

Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators.

R. Casamitjana, W. Jiménez, V. Arroyo, 1998, The Journal of clinical endocrinology and metabolism.

Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization.

W. Jiménez, V. Arroyo, J. Balasch, 2002, Fertility and sterility.

Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines.

W. Jiménez, V. Arroyo, J. Balasch, 2002, Fertility and sterility.

Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.

J. Balasch, F. Fábregues, M. Creus, 1996, Human reproduction.

Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.

R. Casamitjana, M. Tena-Sempere, J. Balasch, 2009, The Journal of clinical endocrinology and metabolism.

Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.

R. Casamitjana, J. Balasch, F. Fábregues, 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction.

R. Casamitjana, J. Balasch, F. Carmona, 2003, Reproductive biomedicine online.

Pregnancy: Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome

J. Balasch, J. Font, M. Ingelmo, 1993 .

Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome.

J. Balasch, J. Font, M. Ingelmo, 1993, Human reproduction.

Pregnancy after Orthotopic Ovarian Tissue Transplantation Using N-hexyl-2-cyanoacrylate

F. Carmona, D. Manau, F. Fábregues, 2017 .

Metastatic ovarian strumosis in an in-vitro fertilization patient.

J. Balasch, F. Fábregues, J. Vanrell, 1993, Human reproduction.

Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.

R. Casamitjana, J. Balasch, J. Ballescà, 1998, Human reproduction.

Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.

R. Casamitjana, J. Balasch, F. Fábregues, 1995, Human reproduction.

Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy.

J. Balasch, J. Ballescà, F. Fábregues, 1994, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program.

J. Balasch, F. Fábregues, S. Cívico, 1998, Fertility and sterility.

Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass.

R. Casamitjana, J. Balasch, D. Manau, 2004, Reproductive biomedicine online.

Follicular Development and Hormonal Levels Following Highly Purified or Recombinant Follicle-Stimulating Hormone Administration in Ovulatory Women and WHO Group II Anovulatory Infertile Patients

R. Casamitjana, J. Balasch, D. Manau, 1998, Journal of Assisted Reproduction and Genetics.

Follicular Development and Hormonal Levels Following Highly Purified or Recombinant Follicle-Stimulating Hormone Administration in Ovulatory Women Undergoing Ovarian Stimulation After Pituitary Suppression for In Vitro Fertilization: Implications for Implantation Potential

J. Balasch, F. Carmona, F. Fábregues, 2004, Journal of Assisted Reproduction and Genetics.

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.

R. Casamitjana, J. Balasch, F. Fábregues, 2001, Human reproduction.

Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol

J. Balasch, F. Carmona, F. Fábregues, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Second-generation preimplantation genetic testing for aneuploidy in assisted reproduction: a SWOT analysis.

J. Bellver, J. García-Velasco, F. Fábregues, 2019, Reproductive biomedicine online.

Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia.

J. Balasch, J. Ballescà, C. Ascaso, 2000, Human reproduction.

LH in the follicular phase: neither too high nor too low.

J. Balasch, F. Fábregues, 2006, Reproductive biomedicine online.

A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.

R. Casamitjana, J. Balasch, F. Fábregues, 2003, Reproductive biomedicine online.

Early Hormonal Markers of Pregnancy Outcome After In Vitro Fertilization and Embryo Transfer

R. Casamitjana, J. Balasch, F. Carmona, 2003, Journal of Assisted Reproduction and Genetics.

Recombinant Human Follicle-Stimulating Hormone for Ovulation Induction in Polycystic Ovary Syndrome: A Prospective, Randomized Trial Of Two Starting Doses in a Chronic Low-Dose Step-up Protocol

R. Casamitjana, J. Balasch, F. Fábregues, 2000, Journal of Assisted Reproduction and Genetics.

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.

R. Casamitjana, J. Balasch, F. Carmona, 2000, Human reproduction.

Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.

R. Casamitjana, J. Balasch, F. Fábregues, 2000, Human reproduction.

Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.

J. Balasch, D. Manau, F. Fábregues, 2006, Fertility and sterility.

Materno‐fetal Immunogenetic Disparity: The Biological Basis for In vitro Fertilization Treatment in Patients with Unexplained Recurrent Abortion?

J. Balasch, F. Carmona, F. Fábregues, 2003, American journal of reproductive immunology.

Immunological factors in endometriosis-associated reproductive failure: studies in fertile and infertile women with and without endometriosis.

J. Balasch, F. Fábregues, M. Creus, 1997, Human reproduction.

Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.

J. Balasch, F. Carmona, D. Manau, 2009, Human reproduction.

Pregnancy after drug-free in vitro activation of follicles and fresh tissue autotransplantation in primary ovarian insufficiency patient: a case report and literature review

F. Carmona, D. Manau, F. Fábregues, 2018, Journal of Ovarian Research.

In-vitro fertilization treatment for unexplained recurrent abortion: a pilot study.

J. Martorell., J. Balasch, F. Fábregues, 1996, Human reproduction.

Hysteroscopic septum resection and reproductive medicine: A SWOT analysis.

J. Bellver, J. García-Velasco, F. Fábregues, 2018, Reproductive biomedicine online.

Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial.

J. Balasch, D. Manau, F. Fábregues, 1997, Human reproduction.

Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.

R. Casamitjana, J. Balasch, F. Carmona, 2006, Human reproduction.

Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study.

J. Balasch, F. Carmona, F. Fábregues, 1996, Human reproduction.

Clinical Assisted Reproduction: The Effect of Exogenous Luteinizing Hormone (LH) on Oocyte Viability: Evidence from a Comparative Study Using Recombinant Human Follicle-Stimulating Hormone (FSH) Alone or in Combination with Recombinant LH for Ovarian Stimulation in Pituitary-Suppressed Women Undergo

R. Casamitjana, J. Balasch, F. Carmona, 2001, Journal of Assisted Reproduction and Genetics.

Evaluation of two doses of recombinant human luteinizing hormone supplementation in down-regulated women of advanced reproductive age undergoing follicular stimulation for IVF: a randomized clinical study.

J. Balasch, F. Carmona, F. Fábregues, 2011, European journal of obstetrics, gynecology, and reproductive biology.

The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.

R. Casamitjana, J. Balasch, F. Fábregues, 2001, Journal of assisted reproduction and genetics.

LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.

R. Casamitjana, J. Balasch, F. Carmona, 2003, Human reproduction.

Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin.

J. Balasch, F. Fábregues, S. Cívico, 1999, Human reproduction.

Age, independent from ovarian reserve status, is the main prognostic factor in natural cycle in vitro fertilization.

J. Balasch, F. Carmona, D. Manau, 2016, Fertility and sterility.

Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle.

J. Balasch, D. Tàssies, J. Reverter, 1998, Human reproduction.

Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.

I. Solá, F. Fábregues, M. A. Checa, 2012, Reproductive biomedicine online.

The role of thrombophilias in reproduction: A swot analysis.

F. Fábregues, J. Llácer, A. Requena, 2022, European journal of obstetrics, gynecology, and reproductive biology.

Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation.

J. Balasch, D. Braat, O. Bukulmez, 2000, Human reproduction.

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.

F. Fábregues, A. Requena, M. A. Checa, 2005, Human reproduction update.

Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression.

R. Casamitjana, J. Balasch, F. Carmona, 2010, Fertility and sterility.

Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.

R. Casamitjana, J. Balasch, D. Manau, 2005, Human reproduction.

Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.

J. Balasch, F. Fábregues, J. Vanrell, 2004, Fertility and sterility.

Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.

R. Casamitjana, J. Balasch, F. Carmona, 2005, Human reproduction.

Transvaginal intratubal insemination, ectopic pregnancy and treatment by single-dose parenteral methotrexate.

R. Casamitjana, J. Balasch, J. Ballescà, 1992, Human reproduction.

Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.

J. Balasch, F. Fábregues, M. Creus, 2001, Human reproduction.

The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age

R. Casamitjana, C. Castelo-Branco, J. Balasch, 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ovarian Reserve Test with Human Menopausal Gonadotropin as a Predictor of In Vitro Fertilization Outcome

R. Casamitjana, J. Balasch, F. Carmona, 2004, Journal of Assisted Reproduction and Genetics.

Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles.

J. Balasch, J. Ballescà, F. Fábregues, 1994, Human reproduction.

Human chorionic gonadotrophin stimulation test as a predictor of ovarian response and pregnancy in IVF cycles stimulated with GnRH agonist gonadotrophin treatment: a pilot study.

R. Casamitjana, J. Balasch, F. Carmona, 2012, Human reproduction.

Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization.

R. Casamitjana, J. Balasch, F. Fábregues, 2005, Fertility and sterility.

Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism.

Juan Balasch, J. Balasch, F. Fábregues, 2003, Reproductive biomedicine online.

R. Casamitjana, J. Balasch, F. Carmona, 2001 .

Osteopontin and alphavbeta3 integrin expression in the endometrium of infertile and fertile women.

E. Campo, J. Ordi, R. Casamitjana, 2008, Reproductive Biomedicine Online.

Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer.

J. Martorell., J. Balasch, J. Font, 1996, Fertility and sterility.

Human chorionic gonadotrophin stimulation test as a predictor of ovarian response and pregnancy in IVF cycles stimulated with GnRH agonist gonadotrophin treatment: a pilot study.

R. Casamitjana, J. Balasch, F. Carmona, 2012, Human reproduction.

Initial analysis of variability among basal hormone biomarkers of ovarian reserve.

R. Casamitjana, J. Balasch, F. Carmona, 2004, Reproductive biomedicine online.